Citadel Advisors’s Allergan Inc AGN Stock Holding History

Citadel Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-79,400	Closed	-$16.9M	–	9378
2014 Q4	$16.9M	Sell	79,400 -51,700	-39%	-$10.3M	0.02%	1059
2014 Q3	$23.4M	Sell	131,100 -125,900	-49%	-$20.9M	0.02%	821
2014 Q2	$43.5M	Buy	257,000 +148,900	+138%	+$23.2M	0.05%	444
2014 Q1	$13.4M	Sell	108,100 -40,200	-27%	-$4.89M	0.02%	1086
2013 Q4	$16.5M	Buy	148,300 +40,300	+37%	+$3.85M	0.02%	917
2013 Q3	$9.77M	Sell	108,000 -10,400	-9%	-$934K	0.01%	1119
2013 Q2	$9.97M	Buy	+118,400	New	+$12.3M	0.02%	1069

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citadel Advisors's AGN Position: Q1 2015 in Review

Citadel Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 708,361 shares — an estimated $151M sold.

Citadel Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $259M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Citadel Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Citadel Advisors sold 708,361 Allergan Inc shares in Q1 2015, an estimated $151M.
Citadel Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Citadel Advisors's Allergan Inc position peaked at $259M in Q4 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.